English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 21 July 2023, 20:50 HKT/SGT
Share:
Peijia Medical Announces its Unaudited Operating Statistics for the First Half of 2023
Revenue is expected to rise 85% to 94% year-on-year

HONG KONG, July 21, 2023 - (ACN Newswire) - July 21, 2023, Peijia Medical Limited ("Peijia Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 9996.HK) announced its certain 2023 unaudited operating statistics of the Group for the six months ended June 30, 2023 ("the first half of 2023") today, the revenue is expected to increase 85.2 to 93.6% year-on-year, to approximately RMB220 million to RMB230 million.

The increase in revenue in the first half of 2023 was primarily attributable to the commercialization of transcatheter aortic valve replacement products (including the first-generation product TaurusOne and the second-generation retrievable product TaurusElite), which has been accelerated, further increasing the Group's market share.

In addition, benefiting by the sales volume of the Group's existing neurointerventional products (including Tethys Intermediate Catheter, SacSpeed Balloon Dilatation Catheter, Jasper Detachable Coil and Syphonet Stent Retriever, etc.) has increased constantly, hence continuously contributing to the revenue growth of the Group.

Meanwhile, the Group's ischemic products (including Fastunnel Delivery Balloon Dilatation Catheter, etc.) whose registration applications were approved by the National Medical Products Administration of the PRC in the second quarter of 2022, have since been commercialized, also contributing to the increase in the revenue of the Group.

As the Company is still in the process of finalizing the interim results of the Group for the first half of 2023. The above operating information is provided for investors' reference only.

About Peijia Medical Limited
Peijia Medical, headquartered in Suzhou, Jiangsu Province, China, was established in 2012 and listed on the Main Board of the Hong Kong Stock Exchange in May 2020 (Stock Code: 9996. HK). Adhering to the corporate vision of "Dedication with Passion, Devotion for Life", always put life and safety first, cultivate technology deeply, persist in innovation, and do as much as it can for helping life and health. With the strategic layout of "Innovation-oriented, Simultaneous Treatment of Heart and Cerebrovascular Diseases" and focusing on the innovation, R&D and production of high-end medical devices for structural heart and cerebrovascular disease intervention, Peijia Medical covers the entire product pipeline for aortic, mitral and tricuspid valve replacements and surgical instruments and accessories, as well as diseases related to hemorrhagic, ischemic and vascular access in the field of neurointervention, built a relatively comprehensive product portfolio and solutions in the field of structural heart and neurovascular diseases in China.


Topic: Press release summary Sectors: BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Gold Basin Resources Refutes Helix Resources April 29, 2026 ASX Annoucement  
May 5, 2026 22:00 HKT/SGT
Digi Power X Signs AI Colocation Agreement with Leading AI Compute Company for 40 MW Data Center in Columbiana, Alabama  
May 5, 2026 20:00 HKT/SGT
Adyton Reports High-Grade Interval at Gameta Development Project of 28.5g/t Au over 12.0m Including 226g/t Au over 1.0m, Fergusson Island, PNG  
May 5, 2026 19:29 HKT/SGT
The Machine Era of Spam Calls: The Ten Most Spammed Countries in the World  
May 5, 2026 15:19 HKT/SGT
Holista Executes Binding JV for Collie Collagen Facility  
May 5, 2026 11:23 HKT/SGT
ZOQQ Approaches Breakeven on a Bootstrapped Path - Bucking the Burn-First Fintech Playbook  
May 5, 2026 07:00 HKT/SGT
TaxiNexo Accelerates Global Expansion: Autonomous Taxis Arrive in Los Angeles  
May 4, 2026 23:30 HKT/SGT
As bossware backlash grows, Vaiz launches work management built on trust, not tracking  
May 4, 2026 23:00 HKT/SGT
Pacific Avenue Capital Partners Enters into Exclusive Negotiations to Acquire ESE World, Amcor's European Waste Container Business  
May 4, 2026 15:30 HKT/SGT
6 Ways to Get More Rewards and Experiences from Everyday Spending  
May 4, 2026 14:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575